USPTO Examiner STIGELL THEODORE J - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19094761APPARATUS AND METHODS FOR TISSUE ABLATIONMarch 2025September 2025Allow510YesNo
18984900HOLD ASSISTANCE DEVICE FOR USE WITH A MEDICAMENT DELIVERY DEVICEDecember 2024April 2025Allow310NoNo
18984873HOLD ASSISTANCE DEVICE FOR USE WITH A MEDICAMENT DELIVERY DEVICEDecember 2024April 2025Allow410NoNo
18867196PERFORATING CONNECTOR FOR MEDICAL FLUID CONTAINERSNovember 2024January 2025Allow200YesNo
18726079ANGIOPLASTY BALLOON CATHETER FOR TREATING VASCULAR DISEASEJuly 2024December 2024Allow500NoNo
18740798DEVICES FOR USE IN DRUG DELIVERY SYSTEMSJune 2024July 2025Allow1310NoNo
18663161Elastomeric Enteral Feeding Pump and Filling SystemMay 2024September 2025Allow1620YesNo
18651779MANUAL INTRAOSSEOUS DEVICE AND METHOD FOR INTRODUCING A BONE PORTAL TO A PREDETERMINED DEPTH IN A BONEMay 2024July 2025Allow1410NoNo
18639152Medical Needle Placement Device and Methods of Using the SameApril 2024September 2024Allow501NoNo
18637830METHOD AND APPARATUS FOR SUPRACHOROIDAL ADMINISTRATION OF THERAPEUTIC AGENTApril 2024May 2025Allow1310NoNo
18612266FLUID PATH CONNECTORS FOR MEDICAL FLUID DELIVERYMarch 2024February 2026Allow2320NoNo
18602168Medicament Delivery DeviceMarch 2024April 2025Allow1320YesNo
18598818FLUID CONDUIT INSERTION DEVICESMarch 2024July 2025Allow1631YesNo
18687152INTEGRATED CARTRIDGE ASSEMBLY FOR ADMINISTRATION OF DRUGSFebruary 2024June 2024Allow300NoNo
18438021MEDICAL TUBING ORGANIZATIONAL DEVICE AND METHOD OF USEFebruary 2024May 2024Allow300YesNo
18405237METHODS AND DEVICES FOR VASCULAR ACCESSJanuary 2024November 2024Allow1020YesNo
18399077SYSTEMS AND METHODS FOR MIXING SYRINGE VALVE ASSEMBLIESDecember 2023April 2025Allow1610NoNo
18525383TROCAR POSITIONING APPARATUS AND METHODS FOR USENovember 2023February 2025Allow1411NoNo
18524409VASCULAR OCCLUSION AND DRUG DELIVERY DEVICES, SYSTEMS, AND METHODSNovember 2023August 2024Allow800NoNo
18519168INTRODUCER SHEATHNovember 2023February 2025Allow1410NoNo
18513818HIGH FLOW, NEEDLELESS CONNECTORNovember 2023July 2024Allow800NoNo
18504574Single Use Safety Needle GuardNovember 2023December 2024Allow1310NoNo
18385357Access Port Locator and Methods of Use ThereofOctober 2023February 2025Allow1610NoNo
18380705GUIDE EXTENSION CATHETEROctober 2023January 2025Allow1511NoNo
18379888DEVICES FOR USE IN DRUG DELIVERY SYSTEMSOctober 2023December 2023Allow200YesNo
18379902DEVICES FOR USE IN DRUG DELIVERY SYSTEMSOctober 2023April 2024Allow610NoNo
18286859DEVICES FOR USE IN DRUG DELIVERY SYSTEMSOctober 2023January 2024Allow400NoNo
18482908Systems and Methods for Proportional Pressure and Vacuum Control in Surgical SystemOctober 2023April 2025Allow1800NoNo
18472579COMPLEX IRRIGATION/SUCTION FLOW PATH IN A MEDICAL DEVICESeptember 2023September 2025Allow2441NoNo
18280767MANUAL INTRAOSSEOUS DEVICE AND METHOD FOR INTRODUCING A BONE PORTAL TO A PREDETERMINED DEPTH IN A BONESeptember 2023March 2024Allow600NoNo
18462799INDWELLING ASSEMBLYSeptember 2023October 2024Allow1410NoNo
18452063EXPANDABLE ACCESS SYSTEMS AND METHODSAugust 2023January 2025Allow1720NoNo
18233193SYSTEMS AND METHODS FOR MIXING SYRINGE VALVE ASSEMBLIESAugust 2023December 2023Allow410YesNo
18446677Liquid Applicator for Delivering VaccinesAugust 2023August 2025Allow2440YesNo
18223639IMPLANTABLE ACCESS PORT WITH ONE-DIRECTIONAL FILTERJuly 2023November 2024Allow1611NoNo
18353641PUMP SYSTEMS WITH POSITIONING FEATURESJuly 2023May 2025Allow2221YesNo
18215438INFUSION SYSTEM AND COMPONENTS THEREOFJune 2023September 2024Allow1510NoNo
18341006AUTOMATED INSERTION ASSEMBLYJune 2023September 2024Allow1510NoNo
18213555SYSTEM AND METHOD FOR AN INJECTION USING A SYRINGE NEEDLEJune 2023September 2024Allow1510NoNo
18207843Catheter Systems and Methods for Medical Procedures Using CathetersJune 2023February 2025Allow2020NoNo
18205285CATHETER INSERTION SYSTEMSJune 2023October 2025Allow2810NoNo
18204718Cap for Medical InjectorJune 2023August 2024Allow1410YesNo
18324081IRRIGATION AND ASPIRATION DEVICE AND METHODMay 2023September 2023Allow400YesNo
18318778System for Aseptic Collection and Enteral DeliveryMay 2023June 2024Allow1300NoNo
18253027DRIP CHAMBER WITH AUTOMATIC VENT AND SHUTOFFMay 2023March 2024Allow1000NoNo
18309644AUTO INJECTOR WITH VARIABLE PLUNGER FORCEApril 2023November 2024Allow1910NoNo
18139732CATHETER SYSTEM HAVING A PUSH BUTTON NEEDLE RETRACTION MECHANISMApril 2023February 2026Allow3301NoNo
18033672DOSE LOGGING SENSOR SYSTEM WITH ERROR DETECTION FEATUREApril 2023March 2026Abandon3400NoNo
18302539Assembly for a Drug Delivery Device Comprising a Feedback FeatureApril 2023August 2024Allow1610NoNo
18246622DEVICE FOR ANCHORING AN INTRODUCER OF A MEDICAL DEVICE INTO THE HUMAN BODY AND METHOD THEREOFMarch 2023February 2026Allow3510NoNo
18024083DRUG DELIVERY DEVICES WITH A SPINNING NOZZLEMarch 2023March 2026Allow3610NoNo
18111824APPARATUS AND METHODS TO COMMUNICATE FLUIDS AND/OR SUPPORT INTRAOSSEOUS DEVICESFebruary 2023February 2025Allow2420YesNo
18109026METHOD AND DEVICE UTILIZING MEDICAMENT DELIVERY PROTOCOLSFebruary 2023October 2024Allow2010NoNo
18104979TREATMENT OF PAIN ASSOCIATED WITH TOTAL KNEE ARTHROPLASTY WITH SUSTAINED-RELEASE LIPOSOMAL ANESTHETIC COMPOSITIONSFebruary 2023October 2024Allow2030YesNo
18097770INFUSION PUMP ASSEMBLYJanuary 2023August 2024Allow1910NoNo
18095469UV Integrated Disinfecting CapJanuary 2023January 2026Allow3610NoNo
18088731CONTROLLED ARTERIAL/VENOUS ACCESSDecember 2022October 2024Allow2210NoNo
18080650VALVES AND HUBS FOR TUBULAR DEVICES AND METHODS FOR MAKING AND USING THEMDecember 2022March 2025Allow2820NoNo
18008962DEVICE FOR ADMINISTERING A FLUIDDecember 2022October 2025Allow3500NoNo
18061618Balloon-Tipped Pad Delivery CatheterDecember 2022March 2026Abandon3901NoNo
18071835BOLUS PERMISSIONS AND PRIORITIZATION SCHEME FOR INFUSION PUMP SYSTEMNovember 2022August 2025Allow3200NoNo
17992106ROTARY DOSAGE SENSING MODULE FOR AND IN A DISPOSABLE PEN DRUG DELIVERY DEVICENovember 2022March 2025Abandon2720NoNo
17989942EXPANDABLE DRIP CHAMBERNovember 2022June 2024Allow1910NoNo
18055295ACCESS PORT SYSTEM FOR INTRATHECAL DRUG DELIVERY WITH SELF-ADJUSTING CATHETER LENGTHNovember 2022March 2024Allow1620NoNo
17980113SYRINGE WITH MULTI-STAGE FILLING AND DISPENSINGNovember 2022September 2024Abandon2310NoNo
17980162SYRINGE WITH MULTI-STAGE FILLING AND DISPENSINGNovember 2022March 2025Abandon2811NoNo
18051950MULTIPLE FLUID DELIVERY SYSTEM WITH MULTI-USE DISPOSABLE SET AND FEATURES THEREOFNovember 2022September 2024Allow2211YesNo
17921763CHANNEL SYSTEM IN MEDICAL DEVICE TO HOUSE MATERIALS TO IMPROVE PERFORMANCE AND LONGEVITYOctober 2022February 2026Allow4010YesNo
17970763SYSTEMS AND METHODS FOR PRODUCING MIXTURESOctober 2022January 2026Allow3911YesNo
17969506THERAPEUTIC TREATMENT DEVICE WITH BRAIDED MICROVALVE OCCLUDEROctober 2022February 2026Allow4010NoNo
17919953PRESSURIZATION-TYPE DRUG INJECTOR HAVING DRUG EXPOSURE PREVENTIVE FUNCTIONOctober 2022December 2025Allow3810YesNo
18045739DRUG DELIVERY DEVICE WITH INDICATOROctober 2022May 2025Allow3211NoNo
17960512DEVICES AND METHODS AND AGENT-ASSISTED MEDICAL PROCEDURESOctober 2022August 2024Abandon2210NoNo
17954165STERILE FLUID PATHWAY CONNECTION TO DRUG CONTAINERS FOR DRUG DELIVERY PUMPSSeptember 2022May 2024Abandon2010NoNo
17906671SYRINGE FOR DERMAL REGENERATIONSeptember 2022October 2025Allow3600NoNo
17939465Ablation Equipment for Delivering Non-Thermal Energy to Treat Target Regions of Tissue in Organs and Control Method ThereofSeptember 2022February 2026Allow4220YesNo
17939631ULTRASOUND-PLACED PAIN MANAGEMENT SYSTEM AND METHOD WITH SUBCUTANEOUS CATHETERSeptember 2022March 2023Allow610YesNo
17901005Instrument Delivery Device with Nested HousingSeptember 2022November 2025Allow3911YesNo
17800733FLUID PATH CONNECTORS FOR MEDICAL FLUID DELIVERYAugust 2022November 2023Allow1520NoNo
17890184Low-Profile Single and Dual Vascular Access DeviceAugust 2022January 2026Allow4111NoNo
17799325DRIP CHAMBER INSERT FOR AN INFUSION DEVICE OF A MEDICAL INFUSION SYSTEMAugust 2022March 2026Allow4310NoNo
17819533PERIPHERAL ANTEGRADE PERFUSION AND OCCLUSION DEVICEAugust 2022April 2024Allow2110NoNo
17884150DELIVERY DEVICES AND METHODSAugust 2022March 2024Allow2010YesNo
17794687A GUIDE DEVICE FOR CANNULAS FOR THE COLLECTION OF MICRO-FRAGMENTED SUBCUTANEOUS ADIPOSE TISSUEJuly 2022January 2026Allow4210NoNo
17794849NEEDLE DEVICES FOR ACCESSING LYMPH NODES AND THORACIC DUCTSJuly 2022December 2025Abandon4110NoNo
17810420CATHETERS WITH ENHANCED FLEXIBILITY AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSJuly 2022December 2024Abandon3020YesNo
17810529TRANSVASCULAR ACCESS METHODSJuly 2022September 2024Abandon2620NoNo
17854769SYSTEMS AND METHODS FOR MIXING SYRINGE VALVE ASSEMBLIESJune 2022July 2023Allow1220YesNo
17849780SYSTEMS AND METHODS FOR FLUID DELIVERYJune 2022April 2024Allow2220NoNo
17787169COSMETIC INJECTOR ON WHICH MICRONEEDLES FOR INDUCING ABSORPTION OF COSMETICS ARE MOUNTED, AND MANUFACTURING METHOD THEREFORJune 2022July 2025Allow3720NoNo
17843829Guide Sheath for Vascular ProceduresJune 2022November 2025Abandon4101NoNo
17840253SYRINGE ADAPTER AND GUIDE FOR FILLING AN ON-BODY INJECTORJune 2022December 2023Allow1810YesNo
17784711Control Of An Ultrasonic HandpieceJune 2022July 2025Allow3800NoNo
17782243INJECTION DEVICEJune 2022February 2026Abandon4510NoNo
17825327SIMPLIFIED INSULIN DELIVERY FOR DIABETICSMay 2022May 2025Allow3510YesNo
17773881BALLOON CATHETER WITH HYDROGEL COATINGMay 2022August 2025Allow4010NoNo
17732221HAIR GROWTH APPLICATOR AND METHOD OF USEApril 2022December 2025Abandon4311NoNo
17772938Infusion cannula unit made of plasticApril 2022August 2025Abandon4010NoNo
17729605SYSTEMS AND METHODS FOR DELIVERING BIOMATERIALSApril 2022January 2024Allow2111YesNo
17717450Flexible Cap for Conical ConnectorsApril 2022August 2023Allow1610YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner STIGELL, THEODORE J.

Strategic Value of Filing an Appeal

Total Appeal Filings
11
Allowed After Appeal Filing
4
(36.4%)
Not Allowed After Appeal Filing
7
(63.6%)
Filing Benefit Percentile
60.1%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 36.4% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner STIGELL, THEODORE J - Prosecution Strategy Guide

Executive Summary

Examiner STIGELL, THEODORE J works in Art Unit 3783 and has examined 502 patent applications in our dataset. With an allowance rate of 84.9%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 34 months.

Allowance Patterns

Examiner STIGELL, THEODORE J's allowance rate of 84.9% places them in the 61% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by STIGELL, THEODORE J receive 1.91 office actions before reaching final disposition. This places the examiner in the 46% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by STIGELL, THEODORE J is 34 months. This places the examiner in the 45% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +13.8% benefit to allowance rate for applications examined by STIGELL, THEODORE J. This interview benefit is in the 52% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 37.5% of applications are subsequently allowed. This success rate is in the 86% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 54.4% of cases where such amendments are filed. This entry rate is in the 80% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 120.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 83% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 81.8% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 45.5% are granted (fully or in part). This grant rate is in the 39% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 6.6% of allowed cases (in the 89% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 9.9% of allowed cases (in the 89% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.